Published in

Wiley, Human Mutation: Variation, Informatics and Disease, 3(4), p. 178-194, 1994

DOI: 10.1002/humu.1380040303

Links

Tools

Export citation

Search in Google Scholar

Genetic heterogeneity of apolipoprotein E and its influence on plasma lipid and lipoprotein levels

This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Apolipoprotein E (apoE) is one of the major protein constituents of chylomicron and very-low-density lipoprotein (VLDL) remnants and plays a central role as a ligand in the receptor-mediated uptake of these particles by the liver. Including the most common variant, apoE3, 30 apoE variants have been characterized. At present, 14 apoE variants have been found to be associated with familial dysbetalipoproteinemia, a genetic lipid disorder characterized by elevated plasma cholesterol and triglyceride levels and an increased risk for atherosclerosis. Seven apoE variants were found to be associated with other forms of hyperlipoproteinemia. This report presents an overview of all currently known apoE variants and their effects on lipoprotein metabolism. Chemicals/CAS: Apolipoproteins E; DNA, 9007-49-2; Lipids; Lipoproteins